CDA and chronic myelogenous leukemia, BCR-ABL1 positive: As shown in Table 2 and compared with donors of hematopoietic stem cell transplantation, CML and AL patients showed an increased enzymatic activity of CDA (all p < 0.001), while the enzymatic activity of CDA between CML and AL patients showed no significant difference.